IQVIA Holdings Inc. closed 26.45% below its 52-week high of $256.34, which the company achieved on March 19th.

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of IQVIA Holdings Inc. (NYSE:IQV) as an investment opportunity by projecting its future cash flows and ...

IQVIA Holdings Inc. closed 29.34% below its 52-week high of $256.76, which the company reached on March 14th.

IQVIA Holdings Inc. IQV is gaining from a massive addressable market, providing it with the opportunity to expand. An ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target ...

Highlights,Victory Capital Management Inc. reduced its stake in IQVIA Holdings Inc. during the fourth quarter.,Several ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on IQV: IQVIA Holdings NewsMORE ...

Principal Financial Group Inc. lowered its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 4.4% in the fourth quarter, according to its most recent 13F filing with the SEC.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa ...

IQVIA Holdings is the world's largest provider of biopharmaceutical development services and commercial outsourcing services. The company is the result of the 2016 merger of Quintiles ...